People: AngioDynamics Inc (ANGO.O)

ANGO.O on Nasdaq

10.68USD
17 May 2013
Price Change (% chg)

$0.00 (+0.00%)
Prev Close
$10.68
Open
$10.73
Day's High
$10.73
Day's Low
$10.57
Volume
58,979
Avg. Vol
120,716
52-wk High
$12.91
52-wk Low
$9.52

Search Stocks

Summary

Name Age Since Current Position

Vincent Bucci

 57 2007 Independent Chairman of the Board

Joseph DeVivo

 45 2011 President, Chief Executive Officer, Director

Mark Frost

 49 2013 Chief Financial Officer, Executive Vice President

George Bourne

 52 2012 Senior Vice President, Chief Technology & Operations Officer

Stephen McGill

 51 2009 Senior Vice President, General Manager - International

Alan Panzer

 51 2012 Senior Vice President, General Manager - US Sales

Matthew Kapusta

 40 2011 Senior Vice President - Business Development

Louis Mazzarese

 2012 Senior Vice President, Chief Regulatory Officer

John Soto

 2012 Senior Vice President - Global Franchise, Peripheral Vascular

Richard Stark

 47 2012 Senior Vice President - Global Franchise, Oncology/Surgery

Charles Greiner

 45 2012 Vice President - Global Franchise, Vascular Access

David Burgstahler

 44 2012 Independent Director

Howard Donnelly

 51 2004 Independent Director

Jeffrey Gold

 64 1997 Independent Director

Kevin Gould

 58 2010 Independent Director

Wesley Johnson

 54 2007 Independent Director

Steven LaPorte

 62 2007 Independent Director

Dennis Meteny

 59 2004 Independent Director

Sriram Venkataraman

 40 2012 Independent Director

Gregory Gin

 IR Contact Officer
» Insider Trading

Biographies

Name Description

Vincent Bucci

 Mr. Vincent A. Bucci is Independent Chairman of the Board of AngioDynamics, Inc. He joined the Company's Board of Directors in January 2007 and was named Chairman in July 2007. From 1999 to 2007, Mr. Bucci served as Chairman of the Board of Directors of RITA Medical Systems, Inc., which the Company acquired in January 2007. In addition, Mr. Bucci serves as Chairman of the Board of IMI Intelligent Medical Implants GmbH and as a director of Northwood Medical Implants, a London based company. Since 1992, Mr. Bucci has been President of Health Policy Associates, Inc., a consulting company he founded. Prior to that, Mr. Bucci spent 11 years with Pfizer Hospital Products Group. Mr. Bucci holds a B.A. from Bates College and a J.D. in Public Law and an M.A. in Government, both from Georgetown University. Mr. Bucci is a member of Company's Licensing and Acquisition Committee.

Joseph DeVivo

 Dr. Joseph M. DeVivo is President, Chief Executive Officer, Director of AngioDynamics Inc., since September 7, 2011. Prior to his appointment as President and Chief Executive Officer, Mr. DeVivo served as Global President of Smith & Nephew Orthopedics, a provider of medical devices operating in the orthopedics, endoscopy and advanced wound management markets, from June 2007 to August 2011. From August 2003 until its acquisition by AngioDynamics in January 2007, Mr. DeVivo served as President and Chief Executive Officer of RITA Medical Systems, a provider of medical oncology devices. Mr. DeVivo served as President, Chief Operating Officer and Director of Computer Motion Incorporation (CMI), a medical robotics company, from August 2002 to July 2003, and as Vice President and General Manager of a division of Tyco International’s Healthcare Business, U.S. Surgical/Davis and Geck Sutures, from May 1993 to August 2002. Mr. DeVivo earned his Bachelor of Science degree in Business Administration from the E. Clairborne Robins School of Business at the University of Richmond in 1989.

Mark Frost

 Mr. Mark T. Frost has been appointed as Chief Financial Officer, Executive Vice President of Angiodynamics Inc. effective January 31, 2013. He served as Chief Financial Officer and Senior Vice President of Administration of Albany Molecular Research Inc., a global drug services company, from December 2004 through September 2012. Prior to Albany Molecular Research Inc., Mr. Frost served five years as vice president of finance at Smith & Nephew Endoscopy, a global medical device division of Smith & Nephew PLC, from September 1999 through November 2004. Prior to that time, Mr. Frost was employed by General Electric for 14 years, where he last served as Chief Financial Officer of Groupe Sovac Auto Financial Services based in Paris, France. Mr. Frost earned a Bachelor of Arts in International Relations/Economics from Colgate University in Hamilton, New York in 1985, and completed the global executive program at INSEAD in 2002.

George Bourne

 Mr. George W. Bourne has been appointed as Senior Vice President, Chief Technology & Operations Officer of AngioDynamics, Inc., effective December 17, 2012. Previously Mr. Bourne was Senior Vice President and Chief Technology Officer for the Company, joining in May, 2012. Prior to joining AngioDynamics, Mr. Bourne served as VP of R&D at Hologic, and before this served as Senior Vice President of R&D and Clinical Affairs for Navilyst Medical from its formation in early 2008 until November 2011. His tenure was defined by focused portfolio development and the commercialization of new products. He also served 10 years at Boston Scientific as Vice President, R&D, of the Urology, Meditech and Oncology business units and then as Group Vice President, R&D, for the endosurgery business group. Mr. Bourne earned his Bachelor of Science in Biological Science and Master of Science in Plastics Engineering from the University of Lowell, in addition to his MBA from Rivier College in Nashua, N.H. He also served in leadership positions at Baxter Healthcare, Allegiance Healthcare and C.R. Bard.

Stephen McGill

 Mr. Stephen J. McGill is Senior Vice President, General Manager - International of AngioDynamics Inc., since November 1, 2009. Mr. McGill has over 27 years of global medical device experience including increasing roles in sales, marketing, operations leadership business development and general management. Mr. McGill was previously with American Medical Systems, where he spent 8 years most recently as Senior Vice President of Global Sales. Prior to American Medical Systems, Mr. McGill has held positions with Boston Scientific, Bolton Medical, Stryker and Allergan.

Alan Panzer

 Mr. Alan Panzer is Senior Vice President, General Manager - US Sales of AngioDynamics Inc. He joined AngioDynamics in September 2011 as Senior Vice President and General Manager of the Vascular Division and was recently promoted to his current position of Senior Vice President, and General Manager – US Sales. Mr. Panzer most recently served as President & CEO of DeVilbiss Healthcare. Prior to DeVilbiss, Mr. Panzer was President of United States Surgical & Valleylab, now a business unit of Covidien. He also has served as a member of the Multiple Myeloma Research Foundation Board. Mr. Panzer earned his Bachelor of Science in Pharmacy from St. John’s University in New York.

Matthew Kapusta

 Mr. Matthew Kapusta is Senior Vice President - Business Development of AngioDynamics Inc., since November 15, 2011. Most recently, Mr. Kapusta served as Vice President of Strategic Planning and Financial Analysis for Smith & Nephew Orthopaedics. Mr. Kapusta also spearheaded strategic and financial planning for Smith & Nephew’s global Hips, Knees and Trauma franchises. Prior to Smith & Nephew, Mr. Kapusta was a Managing Director of Healthcare Investment Banking at Collins Stewart in New York City. He also previously served as Vice President of Healthcare Mergers and Acquisitions at Wells Fargo Securities, and had similar roles at Robertson Stephens and PaineWebber. Mr. Kapusta earned a BBA in Finance, Accounting, from the University of Michigan and has an MBA in Finance, Business Management, from New York University.

Louis Mazzarese

 Mr. Louis J. Mazzarese has been appointed as the Senior Vice President and Chief Regulatory Officer of Angiodynamics Inc. effective October 3, 2012. Mr. Mazzarese brings more than 40 years of medical device and pharmaceutical experience, including driving strategic planning and professional development within the industry through his consulting practice. Mr. Mazzarese's previous experience includes serving as Chief Regulatory Officer and Vice President, Corporate Regulatory Affairs for Edwards Lifesciences; Vice President of Regulatory and Clinical Affairs at Tyco Healthcare; and Vice President of Quality and Regulatory/Clinical Affairs at U.S. Surgical. Earlier in his career, he gained management experience at Pfizer-Shiley, Squibb Corporation, Ciba-Giegy, American McGaw and International Pharmaceutical Products. Additionally, Mr. Mazzarese, who has a B.S. and M.S. in chemistry from Wagner College in Staten Island, N.Y., is past President and Chairman of the Regulatory Affairs Professional Society and a co-founder of the Association of Disposable Device Manufacturers.

John Soto

 Mr. John J. Soto has been appointed as the Senior Vice President - Global Franchise, Peripheral Vascular of AngioDynamics Inc. effective October 3, 2012. Mr. Soto has an expansive background spanning from sales and marketing to international markets and regulatory environments, as well as finance and operations. Most recently he was Senior Vice President of Smith & Nephew's Global Hip Franchise. Mr. Soto is the former Senior Vice President of Global Sales for AngioDynamics -- a role that he took on after the Company's acquisition of RITA Medical Systems in 2007, where he had served as Executive Vice President of Global Sales and Vice President of International Operations. Prior to joining RITA, he gained leadership experience at Computer Motion, Tyco Healthcare and U.S. Surgical. Mr. Soto graduated from the British Royal Navy with a degree in electronic engineering and has a diploma in medical marketing from the University of California at Los Angeles, Calif.

Richard Stark

 Mr. Richard A. Stark is Senior Vice President - Global Franchise, Oncology/Surgery of AngioDynamics Inc. Mr. Stark began his 12-year career with the Company as a District Sales Manager with RITA Medical in 1999, which was acquired by AngioDynamics in 2007, and most recently served as AngioDynamics’ Vice President and General Manager of Sales and Marketing of the Oncology/Surgery Division. Prior to joining RITA, he spent several years in field sales roles at Woodside Biomedical and Arrow/Teleflex. He has a Bachelor’s in Psychology from California State University of Chico in Chico, California.

Charles Greiner

 Mr. Charles R. Greiner is Vice President - Global Franchise, Vascular Access of AngioDynamics Inc. Mr. Greiner joined the Company as a member of the sales team in 1999 where he has held positions of increasing responsibility within the sales and marketing team and most recently served as Vice President Vascular Sales. Prior to AngioDynamics, Mr. Greiner gained management experience at Pharmacia & Upjohn Inc. He has a Bachelor of Science degree in Microbiology from the University of Georgia in Athens, Georgia.

David Burgstahler

 Mr. David Burgstahler is Independent Director of AngioDynamics Inc. He joined the board on May 22, 2012 in connection with Company's acquisition of Navilyst. Mr. Burgstahler is a founding partner of Avista since 2005 and since 2009, has been President of Avista. Prior to forming Avista, he was a partner of DLJ Merchant Banking Partners. He was at DLJ Investment Banking from 1995 to 1997 and at DLJ Merchant Banking Partners from 1997 through 2005. Prior to that, he worked at Andersen Consulting (now known as Accenture) and McDonnell Douglas (now known as Boeing). He holds a Bachelor of Science in Aerospace Engineering from the University of Kansas and a Master of Business Administration from Harvard Business School. Mr. Burstahler currently serves as a Director of Armored AutoGroup Inc., Cidron Healthcare Limited (ConvaTec), INC Research Holdings, Inc., Lantheus Medical Imaging, Visant Corporation and WideOpenWest, LLC. He previously served as a Director of BioReliance Holdings and Warner Chilcott plc.

Howard Donnelly

 Mr. Howard W. Donnelly is Independent Director of AngioDynamics Inc., since March 2004. Mr. Donnelly is President of Concert Medical, LLC, a manufacturer of interventional medical devices. On July 30, 2010, Mr. Donnelly became a principal and President and CEO of HydroCision Inc., a company focused on the spine surgery market. In addition, Mr. Donnelly is a principal in a privately held start-up medical device company targeting the regional anesthetic market. From 2002 to 2008, Mr. Donnelly was a director and member of the audit, compensation and nominating and governance committees of Vital Signs, Inc. From 1999 to 2002, he was President of Level 1, Inc., a medical device manufacturer and a subsidiary of Smiths Group. From 1990 to 1999, Mr. Donnelly was employed at Pfizer, Inc., with his last position as Vice President, Business Planning and Development, for Pfizer’s Medical Technology Group from 1997 to 1999. Mr. Donnelly holds a B.S. and an M.B.A. from Bryant College. Mr. Donnelly is chairman of Company's Licensing and Acquisition Committee and a member of Company's Audit Committee.

Jeffrey Gold

 Mr. Jeffrey G. Gold is Independent Director of AngioDynamics Inc., since 1997. Mr. Gold is a Venture Partner for Longitude Capital, a healthcare venture capital fund. Mr. Gold was President and CEO of CryoVascular Systems, a peripheral vascular disease device company, from 2001 through its sale to Boston Scientific in 2005. From 1997 to 2000, he was Executive Vice President and Chief Operating Officer of Cardio Thoracic Systems, Inc., a company engaged in the development and introduction of devices for beating-heart coronary bypass surgery. Prior to that, Mr. Gold spent 18 years with Cordis Corporation in a variety of senior management roles including Vice President of Manufacturing and Vice President of Research and Development, and was a co-founder and President of Cordis Endovascular Systems, a subsidiary engaged in the interventional neuroradiology business. At Cordis, Mr. Gold also had responsibility for its peripheral vascular business. He serves on the board of directors of several start-up medical device companies and is a member of the Executive Committee for the Center for Entrepreneurship and Innovation at the University of Florida and is a member of the Commercialization Advisory Board for the Cleveland Clinic. Mr. Gold is a member of Company's Licensing and Acquisition Committee and Company's Nominating and Corporate Governance Committee.

Kevin Gould

 Mr. Kevin J. Gould is Independent Director of AngioDynamics Inc., since October 18, 2010. From 1991 to 2007, Mr. Gould held various management positions for the Kendall Company, which later became Tyco Healthcare, a division of Tyco International, Ltd., serving as COO of Tyco Healthcare from 2005 to 2007 and as President, North America, from 2000 to 2005. Tyco Healthcare became a public company in 2007 and is now known as Covidien. Mr. Gould served on the Board of Trustees of St. Elizabeth’s Hospital in Brighton, Massachusetts. Mr. Gould holds a B.A. from St. Anselm’s College in Manchester, New Hampshire and an M.B.A. from Anna Maria College in Paxton, Massachusetts. Mr. Gould is chairman of Company's Compensation Committee and a member of Company's Licensing and Acquisition Committee.

Wesley Johnson

 Mr. Wesley E. Johnson, Jr., is Independent Director of AngioDynamics Inc., since January 29, 2007. From 2003 to 2007, Mr. Johnson served as a member of the board of RITA Medical Systems, Inc. From February 2008 to May 2012, Mr. Johnson served as President, CEO and director of Cardiokinetix, Inc., a developer of medical devices for the treatment of congestive heart failure. From October 2005 to February 2008, Mr. Johnson served as General Manager of Abbott Spine, S.A., a division of Abbott Laboratories. From June 2003 to October 2005, Mr. Johnson served as Division Vice President, Finance for Abbott Spine. From May 1999 to June 2003, he served as Vice President of Operations and Chief Financial Officer for Spinal Concepts. Mr. Johnson holds a B.B.A. in Accounting from Texas A&M University and became a certified public accountant in 1981. Mr. Johnson is a member of Company's Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee.

Steven LaPorte

 Mr. Steven R. LaPorte is Independent Director of AngioDynamics Inc., since January 29, 2007. From 2005 to 2007, Mr. LaPorte served as a member of the board of RITA Medical Systems, Inc. Mr. LaPorte is a Venture Partner for Onset Ventures and serves on the boards of Valeritas and Biocontrol. Mr. Laporte also served as the Chief Technology Officer for Intelect Medical until its acquisition by Boston Scientific in January 2011. From 2002 until his retirement in August 2005, Mr. LaPorte served as the Vice President of NeuroVentures and Business Development at Medtronic, Inc. From 2000 to 2002, Mr. LaPorte served as Vice President and General Manager of Medtronic’s Drug Delivery Division; from 1994 to 2000, he held the position of Vice President and General Manager of Medtronic’s Electrophysiology Systems Division; and from 1988 to 1994 he was the Vice President of Operations for Medtronic’s Neurological Division. He began his career at Medtronic in 1978. Mr. LaPorte received his M.B.A. from the University of Minnesota and a B.S. in mathematics and computer science from the University of Wisconsin Stevens Point. Mr. LaPorte is the chairman of Company's Nominating and Corporate Governance Committee and a member of Company's Compensation Committee.

Dennis Meteny

 Mr. Dennis S. Meteny is Independent Director of AngioDynamics Inc., since March 2004. Mr. Meteny is President and Chief Executive Officer of Cygnus Manufacturing Company LLC, a privately held manufacturer of medical devices, health and safety components, and high precision transportation, aerospace and industrial products. From 2003 to 2006, Mr. Meteny was an Executive-in-Residence at the Pittsburgh Life Sciences Greenhouse, a strategic economic development initiative of the University of Pittsburgh Health System, Carnegie Mellon University, the University of Pittsburgh, the State of Pennsylvania and local foundations. From 2001 to 2003, he was President and Chief Operating Officer of TissueInformatics, Inc., a privately held company engaged in the medical imaging business. From 2000 to 2001, Mr. Meteny was a business consultant to various technology companies. Prior to that, Mr. Meteny spent 15 years in several executive-level positions, including as President and Chief Executive Officer, from 1994 to 1999, of Respironics, Inc. a cardio-pulmonary medical device company. Mr. Meteny holds a B.S. Degree in Accounting from The Pennsylvania State University and an MBA from the University of Pittsburgh. Mr. Meteny is the chairman of Company's Audit Committee.

Sriram Venkataraman

 Mr. Sriram Venkataraman is Independent Director of AngioDynamics Inc. He joined the Company's board on May 22, 2012, in connection with Company's acquisition of Navilyst. Mr. Venkataraman is a Partner of Avista, having joined in May 2007. Prior to joining Avista, Mr. Venkataraman was a Vice President in the Healthcare Investment Banking group at Credit Suisse Group AG from 2001 to 2007. Previously, he worked at GE Healthcare (formerly known as GE Medical Systems) from 1996 to 1999. Mr. Venkataraman holds a Master of Science in Electrical Engineering from the University of Illinois, Urbana-Champaign and a Master of Business Administration with Honors from The Wharton School. He currently serves as a Director of Lantheus Medical Imaging and OptiNose Inc.

Gregory Gin

Insider Trading

Name Shares Traded Price

GOLD JEFFREY G

 2,508 $6.52

BUCCI VINCENT A

 35,000 $10.76

BUCCI VINCENT A

 40,000 $10.78

METENY DENNIS S

 4,600 $10.82

BUCCI VINCENT A

 10,000 $10.80

BUCCI VINCENT A

 2,000 $12.17

FROST MARK T

 20,000 $0.00

MCGILL STEPHEN J

 2,600 $12.35

STARK RICHARD

 838 $12.35

GOULD KEVIN J

 2,700 $11.58

BOURNE GEORGE W IV

 2,000 $0.00

KAPUSTA MATTHEW C

 1,358 $10.12

STARK RICHARD

 3,160 $10.36

GOLD JEFFREY G

 1,000 $10.56

SOTO JOHN

 10,000 $0.00

DEVIVO JOSEPH

 2,526 $12.12

GERSUK D JOSEPH

 1,086 $11.61

STARK RICHARD

 715 $11.61

DEVIVO JOSEPH

 22,247 $0.00

MCGILL STEPHEN J

 15,000 $0.00

PANZER ALAN

 7,500 $0.00

STARK RICHARD

 10,000 $0.00

ETLINGER RICHARD SCOTT

 6,500 $0.00

GERSUK D JOSEPH

 12,000 $0.00

KAPUSTA MATTHEW C

 5,000 $0.00
» Full list on Insider Trading
Search Stocks